A Murine Xenograft Model for Human CD30+ Anaplastic Large Cell Lymphoma
- 1 October 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (4) , 1353-1359
- https://doi.org/10.1016/s0002-9440(10)65237-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation.1999
- ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological SpectrumThe American Journal of Pathology, 1998
- Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.1998
- The t(2;5) in Human LymphomasLeukemia & Lymphoma, 1998
- CD30 ligand in lymphoma patients with CD30+ tumors.Journal of Clinical Oncology, 1997
- Role of Natural Killer Cells on Engraftment of Human Lymphoid Cells and on Metastasis of Human T-Lymphoblastoid Leukemia Cells in C57BL/6J-scidMice and in C57BL/6J-scid bgMiceCellular Immunology, 1996
- Limitations of the Severe Combined Immunodeficiency (SCID) Mouse Model for Study of Human B‐Cell ResponsesScandinavian Journal of Immunology, 1995
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- Establishment of a Human Cutaneous T-Cell Lymphoma in C.B-17 SCID MiceJournal of Investigative Dermatology, 1990
- A severe combined immunodeficiency mutation in the mouseNature, 1983